SCHEMBL21872476

SCHEMBL21872476

Cc1cc2ccn(CC(C)(C)C)c2cc1F

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 11/20 0.46
HTR2A P28223 10/20 0.46
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
HTR2B P41595 1/20 0.39
HTR7 P34969 1/20 0.36
GRIN2B Q13224 2/20 0.36
GRM2 Q14416 1/20 0.36
NR3C1 P04150 1/20 0.33
PGR P06401 1/20 0.33
NR3C2 P08235 1/20 0.33
KDM1A O60341 1/20 0.33
EPHX2 P34913 1/20 0.33
P2RX7 Q99572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26674221 0.93 HTR2C (0.46) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL18911807 0.89 HTR2A (0.43) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL24110357 0.86 HTR2C (0.48) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL21872537 0.85 HTR2A (0.40) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL21872603 0.85 HTR2C (0.40) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL24110247 0.80 HTR2C (0.48) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL21872466 0.80 HTR2C (0.54) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL10165538 0.79 GRIN2B (0.55) HTR2CHTR2AGRIN2B
SCHEMBL24144086 0.79 HTR2C (0.45) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL21872574 0.79 HTR2C (0.45) HTR2CHTR2ACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632443-B1 ANTI-TUMOR EFFECT POTENTIATOR USING A BIPHENYL COMPOUND TAIHO PHARMACEUTICAL CO LTD (JP) 2023-06-07 EP disclosed
EP-3632897-A1 NOVEL BIPHENYL COMPOUND OR SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 EP disclosed